Hanoi (VNA) – Cambodia is looking forward to obtaining herd immunity by November, while Malaysia has granted conditional approval for CanSinoBiologics and Johnson & Johnson COVID-19 vaccines.

Within the next few days, Cambodia will have vaccinatedthree million people towards its target of 10 million, according to Ministry ofHealth spokeswoman Or Vandine.

Vandine, who isalso chairwoman of the national Covid-19 vaccination commission, wrote onTwitter that Cambodians are vaccinated as quickly as possible.

Meanwhile,Prime Minister Hun Sen has decided to take control of the leadership of theNational Committee to Combat COVID-19, with five deputy ministers as deputychairmen.

According to the health ministry’s report on June 13,Cambodia has vaccinated 2,939,543 people nationwide, accounting for 29.40 percentof the target number of 10 million people vaccinated.

The country on June 15 confirmed 495 new COVID-19 cases and 13 deaths,pushing the country's number of infections to 39,464 and the death toll to 361. As many as 604 patients were given the all-clear, takingthe total number of recoveries to 33,571.  

Malaysia has granted conditional approval for emergency useto the single dose COVID-19 vaccines manufactured by China's CanSino Biologicsand the US drug maker Johnson & Johnson, the government said on June 15.

Malaysia would obtain Johnson & Johnson's vaccines viathe global COVAX facility, the healthministry said in a statement.

The government has said previously it had secured 3.5million doses of CanSino's shot, though it has yet to receive any shipments ofthe vaccine.

Malaysia has secured a total of 79.5 million vaccines, includingthose manufactured by Britain's AstraZeneca and Chinese firm Sinovac. A total of3.28 million people, about 10 percent of the population, have received at leastone dose as of Monday, government records show.

Malaysia reported 5,419 new cases on June 15, bringing totalinfections to 667,876./.